Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.
The item "Funds-From-Operation-To-Total-Debt" stands at 37.79 percent as of 09/30/2025, the highest value since 03/31/2023.
As of the end of Eli Lilly and Company's third quarter, the item "Funds From Operation To Total Debt" stands at 37.79 Percent. This represents an increase of 10.38 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.40 percentage points compared to the value the year prior.
The 1 year change in percentage points is 18.40.
The 3 year change in percentage points is -13.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Funds From Operation To Total Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Funds From Operation To Total Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Funds From Operation To Total Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Funds From Operation To Total Debt | 280,205,508,085.11 |
![]() | Novartis AG - Funds From Operation To Total Debt | 255,096,620,580.91 |